Cargando…
Mesenchymal Stem Cells Loaded with p5, Derived from CDK5 Activator p35, Inhibit Calcium-Induced CDK5 Activation in Endothelial Cells
The potential use of stem cells as therapeutics in disease has gained momentum over the last few years and recently phase-I clinical trials have shown favourable results in treatment of a small cohort of acute stroke patients. Similarly, they have been used in preclinical models drug-loaded for the...
Autores principales: | Fang, Wen-Hui, Kumar, Shant, McDowell, Garry, Smith, David, Krupinski, Jurek, Olah, Peter, Al-Baradie, Raid Saleem, Al-Rukban, Mohammad Othman, Petcu, Eugene Bogdan, Slevin, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019892/ https://www.ncbi.nlm.nih.gov/pubmed/27651795 http://dx.doi.org/10.1155/2016/2165462 |
Ejemplares similares
-
Targeting p35/Cdk5 Signalling via CIP-Peptide Promotes Angiogenesis in Hypoxia
por: Bosutti, Alessandra, et al.
Publicado: (2013) -
Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis
por: Zheng, Ya-Li, et al.
Publicado: (2016) -
Resveratrol inhibits Cdk5 activity through regulation of p35 expression
por: Utreras, Elias, et al.
Publicado: (2011) -
Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein
por: Binukumar, B.K., et al.
Publicado: (2015) -
A Cdk5-derived peptide inhibits Cdk5/p25 activity and improves neurodegenerative phenotypes
por: Pao, Ping-Chieh, et al.
Publicado: (2023)